Sangui Biotech International Stock Today
| SGBI Stock | USD 0 0.00 0.00% |
Performance0 of 100
| Odds Of DistressLess than 44
|
Sangui Biotech is trading at 0.0015 as of the 19th of April 2024. This is a No Change since the beginning of the trading day. The stock's open price was 0.0015. Sangui Biotech has about a 44 percent probability of financial distress in the next few years of operation and has generated negative returns over the last 90 days. Equity ratings for Sangui Biotech International are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 20th of March 2024 and ending today, the 19th of April 2024. Click here to learn more.
Sangui Biotech International, Inc., through its subsidiaries, engages in the manufacturing and sales of wound treatment and cosmetic products. Sangui Biotech International, Inc. was incorporated in 1995 and is headquartered in Hamburg, Germany. Sangui Biotech is traded on OTC Exchange in the United States.. The company has 209.9 M outstanding shares. More on Sangui Biotech International
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Sangui Pink Sheet Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Sangui Biotech's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Sangui Biotech or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO | Thomas Striepe |
| Business Concentration | Drug Manufacturers—Specialty & Generic, Healthcare (View all Sectors) |
Sangui Biotech International [SGBI] is a Pink Sheet which is traded between brokers as part of OTC trading. The company currently falls under 'Nano-Cap' category with a current market capitalization of 902.58 K. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Sangui Biotech's market, we take the total number of its shares issued and multiply it by Sangui Biotech's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Sangui Biotech Inter conducts business under Healthcare sector and is part of Drug Manufacturers—Specialty & Generic industry. The entity has 209.9 M outstanding shares.
Sangui Biotech International currently holds about 30.47 K in cash with (140.46 K) of positive cash flow from operations.
Check Sangui Biotech Probability Of Bankruptcy
Ownership AllocationSangui Biotech Inter shows a total of 209.9 Million outstanding shares. Sangui Biotech Inter has 13.03 % of its outstanding shares held by insiders and 0.0 % owned by institutional holders. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Sangui Ownership Details
Sangui Biotech Inter Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Sangui Biotech market risk premium is the additional return an investor will receive from holding Sangui Biotech long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Sangui Biotech. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Sangui Biotech's alpha and beta are two of the key measurements used to evaluate Sangui Biotech's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 0.7553 | |||
| Standard Deviation | 3.97 | |||
| Variance | 15.76 | |||
| Risk Adjusted Performance | 0.0202 |
Sangui Stock Against Markets
Picking the right benchmark for Sangui Biotech pink sheet is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Sangui Biotech pink sheet price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Sangui Biotech is critical whether you are bullish or bearish towards Sangui Biotech International at a given time. Please also check how Sangui Biotech's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Sangui Biotech without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Volatility Analysis Now
Volatility AnalysisGet historical volatility and risk analysis based on latest market data |
| All Next | Launch Module |
How to buy Sangui Pink Sheet?
Before investing in Sangui Biotech, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Sangui Biotech. To buy Sangui Biotech stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Sangui Biotech. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Sangui Biotech stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Sangui Biotech International stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Sangui Biotech International stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Sangui Biotech International, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments.
Already Invested in Sangui Biotech International?
The danger of trading Sangui Biotech International is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Sangui Biotech is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Sangui Biotech. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Sangui Biotech Inter is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sangui Biotech International. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics. Note that the Sangui Biotech Inter information on this page should be used as a complementary analysis to other Sangui Biotech's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Complementary Tools for Sangui Pink Sheet analysis
When running Sangui Biotech's price analysis, check to measure Sangui Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sangui Biotech is operating at the current time. Most of Sangui Biotech's value examination focuses on studying past and present price action to predict the probability of Sangui Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sangui Biotech's price. Additionally, you may evaluate how the addition of Sangui Biotech to your portfolios can decrease your overall portfolio volatility.
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Stocks Directory Find actively traded stocks across global markets | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |